Jane Osbourn

2.9k citations

26 papers · 1.8k indexed · 1 hit paper · h-index 17

Impact in

Radiology, Nuclear Medicine and Imaging top 1%
- Monoclonal and Polyclonal Antibodies Research
Molecular Biology top 10%
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Advanced Biosensing Techniques and Applications

Papers in

Radiology, Nuclear Medicine and Imaging 14
- Monoclonal and Polyclonal Antibodies Research 14
Biotechnology 4
- Transgenic Plants and Applications 4

Co-authors: Tristan J. Vaughan J. C. Earnshaw Kevin S. Johnson John McCafferty Jane Wilton Andrew J Williams Regina A. Hodits Kevin Pritchard
Journals: Nature Biotechnology (3 papers)Immunotechnology (2 papers)Virology (2 papers)British Journal of Cancer (1 paper)Gene (1 paper)
Partner nations: United Kingdom United States Australia

In The Last Decade

Jane Osbourn

24 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library 1996 · 803 citations

Peers

Countries citing papers authored by Jane Osbourn

Since Specialization

Citations

This map shows the geographic impact of Jane Osbourn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Osbourn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Osbourn more than expected).

Fields of papers citing papers by Jane Osbourn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Osbourn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Osbourn. The network helps show where Jane Osbourn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jane Osbourn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane Osbourn Line = papers co-authored together Jane Osbourn links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Predictability of B cell clonal persistence and immunosurveillance in breast cancer Nature Immunology ·Stephen‐John Sammut, Jacob D. Galson, Ralph Minter, Bo Sun, Suet‐Feung Chin, Leticia De Mattos‐Arruda, Donna K. Finch, Sebastian Schätzle, J.C. Dias, Oscar M. Rueda, Joan Seoane, Jane Osbourn, Carlos Caldas, Rachael Bashford-Rogers	2024	10
2	A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy Cancer Cell ·Brian S. Whitehouse, Samuel R. Perry, Vanessa Muniz‐Medina, Xinzhong Wang, Leslie Wetzel, Marlon C. Rebelatto, Mary Jane Hinrichs, Binyam Bezabeh, Ryan Fleming, Nazzareno Dimasi, Hui Feng, Dorin Toader, Andy Q. Yuan, Lan Xu, Jia Lin, Changshou Gao, Herren Wu, Rakesh Dixit, Jane Osbourn, Steven Coats	2016	292
3	A novel in vivo method for isolating antibodies from a phage display library by neuronal retrograde transport selectively yields antibodies against p75^NTR mAbs ·Hiroaki TANI, Jane Osbourn, Edward H. Walker, Robert A. Rush, Ian T. Ferguson	2013	6
4	Applications of ribosome display to antibody drug discovery Expert Opinion on Biological Therapy ·Maria Groves, Jane Osbourn	2005	20
5	From rodent reagents to human therapeutics using antibody guided selection Methods ·Jane Osbourn, Maria Groves, Tristan J. Vaughan	2005	64
6	Current methods for the generation of human antibodies for the treatment of autoimmune diseases Drug Discovery Today ·Jane Osbourn, Lutz Jermutus, Maria Carolina Rodrigues Garcia	2003	33
7	Proximity-Guided (ProxiMol) Antibody Selection Humana Press eBooks ·Jane Osbourn	2003	4
8	Aquaporin-1 Is Expressed by Vascular Smooth Muscle Cells and Mediates Rapid Water Transport across Vascular Cell Membranes Journal of Vascular Research ·Catherine M. Shanahan, Derek Connolly, Kerry Tyson, Nathaniel R.B. Cary, Jane Osbourn, Peter Agre, Peter L. Weissberg	1999	73
9	Signal amplification in flow cytometry using biotin tyramine Cytometry ·J. C. Earnshaw, Jane Osbourn	1999	23
10	Pathfinder selection: in situ isolation of novel antibodies Immunotechnology ·Jane Osbourn, Elaine J. Derbyshire, Tristan J. Vaughan, Janice E. O'Connor, Kevin S. Johnson	1998	35
11	Directed selection of MIP-1α neutralizing CCR5 antibodies from a phage display human antibody library Nature Biotechnology ·Jane Osbourn, J. C. Earnshaw, Kevin S. Johnson, Marc Parmentier, Hideki Kon Torio, John McCafferty	1998	39
12	Antigen specificity and tumour targeting efficiency of a human carcinoembryonic antigen-specific scFv and affinity-matured derivatives British Journal of Cancer ·Heather Jackson, Alison Kent, RB Pedley, Darren Horstmeier, Janice E. O'Connor, Jane Osbourn, Deborah Allen	1998	21
13	Human antibodies by design Nature Biotechnology ·Tristan J. Vaughan, Jane Osbourn, Philip R. Tempest	1998	117
14	Identification of Osteoglycin as a Component of the Vascular Matrix Arteriosclerosis Thrombosis and Vascular Biology ·Catherine M. Shanahan, Nathaniel R.B. Cary, Jane Osbourn, Peter L. Weissberg	1997	78
15	Generation of a panel of related human scFv antibodies with high affinities for human CEA Immunotechnology ·Jane Osbourn, Janice E. O'Connor, Jane Wilton, Elaine J. Derbyshire, J. C. Earnshaw, Lφnning, Deborah Allen, 秀源于	1996	37
16	Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library Nature Biotechnology ·Tristan J. Vaughan, Andrew J Williams, Kevin Pritchard, Jane Osbourn, John A Sayer, J. C. Earnshaw, John McCafferty, Regina A. Hodits, Jane Wilton, Kevin S. Johnson Hit paper breakdown →	1996	803
17	A regulatory element downstream of the rat SM22α gene transcription start point enhances reporter gene expression in vascular smooth muscle cells Gene ·Jane Osbourn, Peter L. Weissberg, Catherine M. Shanahan	1995	24
18	Cloning and analysis of the promoter region of the rat SM22α gene Biochemical Journal ·Paul R. Kemp, Jane Osbourn, David J. Grainger, James C. Metcalfe	1995	38
19	Complementation of coat protein-defective TMV mutants in transgenic tobacco plants expressing TMV coat protein Virology ·Jane Osbourn, Sukamal Sarkar, T. M. A. Wilson	1990	46
20	Evidence that nucleocapsid disassembly and a later step in virus replication are inhibited in transgenic tobacco protoplasts expressing TMV coat protein Virology ·Jane Osbourn, John W. Watts, Roger N. Beachy, T. M. A. Wilson	1989	40

About Jane Osbourn

Jane Osbourn is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology, Molecular Biology, Occupational Therapy and Immunology, having authored 26 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers), Protein purification and stability (5 papers), T-cell and B-cell Immunology (5 papers), Transgenic Plants and Applications (4 papers), Plant Virus Research Studies (3 papers), Nanofabrication and Lithography Techniques (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.3k citations), Molecular Biology (1.3k citations), Biotechnology (158 citations), Immunology (291 citations) and Oncology (362 citations). Jane Osbourn has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Tristan J. Vaughan, J. C. Earnshaw, Kevin S. Johnson, John McCafferty, Jane Wilton, Andrew J Williams, Regina A. Hodits, Kevin Pritchard, Philip R. Tempest and Peter L. Weissberg. Their work appears in journals such as Nature Biotechnology, Immunotechnology, Virology, British Journal of Cancer and Gene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact